These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19122342)

  • 1. Effect of intestinal and hepatic first-pass extraction on the pharmacokinetics of everolimus in rats.
    Yokomasu A; Yano I; Sato E; Masuda S; Katsura T; Inui K
    Drug Metab Pharmacokinet; 2008; 23(6):469-75. PubMed ID: 19122342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of itraconazole on the pharmacokinetics of everolimus administered by different routes in rats.
    Yokomasu A; Yano I; Sato E; Masuda S; Katsura T; Inui K
    Biopharm Drug Dispos; 2009 Dec; 30(9):517-23. PubMed ID: 19790241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats.
    Hashimoto Y; Sasa H; Shimomura M; Inui K
    Pharm Res; 1998 Oct; 15(10):1609-13. PubMed ID: 9794505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of increased bioavailability of tacrolimus in rats with experimental renal dysfunction.
    Okabe H; Yano I; Hashimoto Y; Saito H; Inui K
    J Pharm Pharmacol; 2002 Jan; 54(1):65-70. PubMed ID: 11829131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
    Koster RA; Dijkers EC; Uges DR
    Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologically based pharmacokinetic (PBPK) modeling of everolimus (RAD001) in rats involving non-linear tissue uptake.
    Laplanche R; Meno-Tetang GM; Kawai R
    J Pharmacokinet Pharmacodyn; 2007 Jun; 34(3):373-400. PubMed ID: 17431753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of everolimus.
    Kirchner GI; Meier-Wiedenbach I; Manns MP
    Clin Pharmacokinet; 2004; 43(2):83-95. PubMed ID: 14748618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol.
    Yoon IS; Choi MK; Kim JS; Shim CK; Chung SJ; Kim DD
    Xenobiotica; 2011 Mar; 41(3):243-51. PubMed ID: 21128757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra fast liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of cyclosporin A, tacrolimus, sirolimus, and everolimus in whole blood using deuterated internal standards for cyclosporin A and everolimus.
    Meinitzer A; Gartner G; Pilz S; Stettin M
    Ther Drug Monit; 2010 Feb; 32(1):61-6. PubMed ID: 20010460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
    Koster RA; Alffenaar JW; Greijdanus B; Uges DR
    Talanta; 2013 Oct; 115():47-54. PubMed ID: 24054560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a novel commercial assay for the determination of cyclosporine A, tacrolimus, sirolimus, and everolimus by liquid chromatography-tandem mass spectrometric assay.
    Becker S; Thiery J; Ceglarek U
    Ther Drug Monit; 2013 Feb; 35(1):129-32. PubMed ID: 23188181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.
    Ikemura K; Urano K; Matsuda H; Mizutani H; Iwamoto T; Okuda M
    J Pharmacol Exp Ther; 2009 Jan; 328(1):249-55. PubMed ID: 18842703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption and intestinal metabolism of SDZ-RAD and rapamycin in rats.
    Crowe A; Bruelisauer A; Duerr L; Guntz P; Lemaire M
    Drug Metab Dispos; 1999 May; 27(5):627-32. PubMed ID: 10220493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.
    Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C;
    Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating barriers to bioavailability in vivo: validation of a technique for separately assessing gastrointestinal absorption and hepatic extraction.
    Letendre L; Scott M; Dobson G; Hidalgo I; Aungst B
    Pharm Res; 2004 Aug; 21(8):1457-62. PubMed ID: 15359582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-pass metabolism of ONO-5046 (N-[2-[4-(2,2-dimethylpropionyloxy) phenylsulfonylamino]benzoyl]aminoacetic acid), a novel elastase inhibitor, in rats.
    Watanabe F; Sato M; Kato A; Murakami T; Higashi Y; Yata N
    Biol Pharm Bull; 1997 Apr; 20(4):392-6. PubMed ID: 9145216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of cyclosporin A, tacrolimus, sirolimus, and everolimus in dried blood spot samples using liquid chromatography tandem mass spectrometry.
    den Burger JC; Wilhelm AJ; Chahbouni A; Vos RM; Sinjewel A; Swart EL
    Anal Bioanal Chem; 2012 Oct; 404(6-7):1803-11. PubMed ID: 22899246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of cyclosporine, tacrolimus, sirolimus and everolimus by liquid chromatography coupled to electrospray ionization and tandem mass spectrometry: assessment of matrix effects and assay performance.
    Vethe NT; Gjerdalen LC; Bergan S
    Scand J Clin Lab Invest; 2010 Dec; 70(8):583-91. PubMed ID: 21039189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Shim HJ; Kim YC; Park KJ; Kim DS; Kwon JW; Kim WB; Lee MG
    J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Larger dosage required for everolimus than sirolimus to maintain same blood concentration in two pancreatic islet transplant patients with tacrolimus.
    Sato E; Yano I; Shimomura M; Masuda S; Katsura T; Matsumoto S; Okitsu T; Iwanaga Y; Uemoto S; Inui K
    Drug Metab Pharmacokinet; 2009; 24(2):175-9. PubMed ID: 19430174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.